The Pained Brain was announced on September 21, 2026 in a release distributed nationally through EIN Presswire. The full text is published on painmd.tv, the site of the Padda Institute practice Dr. Padda has led since 2001.
Dr. Gurpreet Singh Padda, MD Publishes The Pained Brain, Arguing Chronic Pain Is a Metabolic Disease the Scan Cannot See
September 21, 2026 · Book launch
The launch release for the book, coauthored with Dr. KrisJay Fucanan, MD. Chronic pain is not a local structural defect waiting for a local repair; it is a centralized nervous-system disease fueled by systemic metabolic inflammation. It costs the United States $722.8 billion a year, degenerative findings on a scan are common in people with no pain at all, and insulin resistance among nondiabetic adults rose from 24.8 to 38.4 percent between 1999 and 2018.
Carried by AP News, The National Law Review and KTVI FOX 2 St. Louis. Read the full release on painmd.tv · Original on EIN Presswire
As Seen In
Our releases ran on AP News, The National Law Review, FOX 2 St. Louis and 630+ other news sites across the United States and Canada.
- 14press releases
- 5,300+news placements
- 630+news outlets
- 110+TV station sites
- AP News
- The National Law Review
- FOX 2 St. Louis
- WGN-TV Chicago
- PIX11 New York
- KRON 4 San Francisco
- Detroit Free Press
- The Detroit News
- The Indianapolis Star
- The Tennessean
- Milwaukee Journal Sentinel
- The Arizona Republic
- The Des Moines Register
- The Cincinnati Enquirer
Distributed by EIN Presswire for Nectar Media Group.
Since the launch
Dr. Gurpreet Singh Padda, MD Puts the New Low-Carb Guideline to Work in Pain Care: Medicines Change Before Pain Does
EIN Presswire, October 7, 2026 · Clinical guideline
The release on the Society of Metabolic Health Practitioners’ guideline for therapeutic carbohydrate reduction, published October 2, 2026 in the Journal of Metabolic Health. Dr. Padda applies it to the pain patient who arrives on a blood pressure pill, a diabetes drug, a nerve medicine and an anti-inflammatory at once: the diet works within days, so every dose change belongs to the doctor from the first day.
Read the full release on EIN Presswire
Later in The Brain
Dr. Gurpreet Singh Padda, MD Publishes The Dopamine Brain: Dopamine Is Not the Pleasure Chemical We Thought
October 5, 2026 · Book launch
The launch release for the fourth book in the series. Dopamine is not the pleasure chemical: it tells you what to get, not what to enjoy. The book follows that one reversal through food, addiction, Parkinson’s therapy and the intensive care unit. Adults on an ultra-processed diet ate 508 calories a day more without rating the food as more pleasant, and among Parkinson’s patients ever treated with a dopamine agonist, 51.5 percent developed an impulse control disorder within five years, against 12.4 percent of those never treated.
Carried by AP News, The National Law Review, KTVI FOX 2 St. Louis, KOLR 10 Springfield and KSN/KODE 12 Joplin. Read the full release on EIN Presswire
Dr. Gurpreet Singh Padda, MD Publishes ‘The Angry Gut, Your First Brain’
September 28, 2026 · Book launch
The launch release for the book, coauthored with Ami Michelle Grimes. The enteric nervous system arrived first in evolutionary time, and the brain in the skull is the later addition, tethered to the gut by the vagus nerve. A starved, permeable, inflamed first brain cannot produce a calm, regulated second one. The book prints measured figures over famous ones: the intestinal surface is about 32 square meters, not the size of a tennis court.
Carried by AP News, The National Law Review, KTVI FOX 2 St. Louis , KOLR 10 Springfield, Columbia Daily Tribune, Springfield News-Leader, KSN/KODE Joplin, The Detroit News, Detroit Free Press, The Indianapolis Star, The Tennessean, Milwaukee Journal Sentinel, The Arizona Republic, Akron Beacon Journal, WGN-TV Chicago, PIX11 New York and WPRI 12 Providence, among more than 850 news sites. Read the full release on Regen.MD · Original on EIN Presswire
Earlier in The Brain
The series’ first book, The Starved Brain, has been the subject of two releases.
Dr. Gurpreet Singh Padda, MD Discusses Alzheimer’s Research, Not Just Plaque
September 21, 2026 · World Alzheimer’s Day
The case that Alzheimer’s disease is a fuel and inflammation failure that begins decades before the plaque. Brain glucose uptake falls early while ketone uptake holds. Insulin competes with amyloid-beta for the same clearing enzyme. In the VITACOG trial, three B vitamins cut brain atrophy 53 percent in patients with high homocysteine. Each of these variables is measurable on tests any primary care office can order.
Carried by AP News, The National Law Review, KTVI FOX 2 St. Louis and the Akron Beacon Journal. Read the full release on Regen.MD · Original on EIN Presswire
New Book The Starved Brain by Dr. Gurpreet Padda Reframes Dementia as a Metabolic Disease of Overnutrition
July 23, 2026 · Book launch
The launch release. Cognitive decline as the malnutrition of excess: a brain overfed on calories and starved of the materials it is built from, organized into four measurable failures of fuel, structure, nutrients and inflammation.
Carried by AP News. Read the full release on Regen.MD · Original on EIN Presswire
Media inquiries: info@regen.md. Releases for every book in the series are distributed by Nectar Media Group through its EIN Presswire newsroom.
More from Dr. Padda in the press
Dr. Gurpreet Singh Padda, MD: The Fat That Inflames the Heart Is Also Burning the Nerves
EIN Presswire, November 17, 2026 · Clinical guideline
Dr. Padda reads the 2026 Obesity Medicine Association statement on obesity and heart disease through the lens of chronic pain. The chemical signals that inflame artery walls also sensitize the small C-fibers and turn up the dorsal root ganglion, and in the UK Biobank chronic widespread pain carried a 48 percent higher adjusted risk of heart attack, stroke, heart failure or cardiovascular death.
Read the full release on EIN Presswire
Dr. Gurpreet Singh Padda, MD: Diabetic Neuropathy Is Treated as One Nerve Problem; It Is Three Different Problems
EIN Presswire, November 14, 2026 · Observance
Dr. Padda marks World Diabetes Day by splitting diabetic neuropathy into three separate problems: a nerve cut off from its blood supply, proteins stiffened by sugar, and slow wear of the nerve’s structure. Each one calls for its own plan. He also explains why a pinched nerve and a sugar-injured nerve can feel alike in the feet, which is why nerve testing comes first.
Read the full release on EIN Presswire
Dr. Gurpreet Singh Padda, MD on Veterans Day: The System Solved the Prescription and Did Not Solve the Pain
EIN Presswire, November 11, 2026 · Observance
Veterans Day is the occasion for Dr. Padda’s case that fewer milligrams of opioid and less pain are separate outcomes. Between 2012 and 2016 the VA brought its count of high-dose patients down to just over 35,000 from about 60,000, and he asks whether anyone tracked the pain. He also weighs the stellate ganglion block, a neck injection studied in PTSD, and its mixed evidence.
Read the full release on EIN Presswire
Dr. Gurpreet Singh Padda, MD: Trial Suggests PRP May Delay Knee Replacement for Patients Already on the Surgical List
EIN Presswire, October 12, 2026 · Research
A randomized trial in which all 90 patients had knee osteoarthritis at grade 3 or 4 and were already listed for replacement is the subject of Dr. Padda’s World Arthritis Day release. Two PRP injections reduced pain and improved function compared with cortisone and an anti-inflammatory. He follows the authors in calling PRP a bridge that may put off surgery, without claiming that cartilage regrows.
Read the full release on EIN Presswire
Dr. Gurpreet Singh Padda, MD: Half of Diabetic Nerve Damage Causes No Symptoms, and It Still Causes Falls
EIN Presswire, September 24, 2026 · Observance
During Falls Prevention Awareness Week, Dr. Padda explains why someone with diabetic neuropathy may look balanced in an office exam yet be at risk on a dim staircase. Steady footing relies on constant signals from the feet. Patients make up for weak signals with a wider stance and by relying on their eyes, which stops working in the dark.
Read the full release on EIN Presswire
International Overdose Awareness Day
EIN Presswire, August 31, 2026 · Observance
Using numbers from patients it treated, not from trials, the practice reported that new patients had lived with pain for over 2.5 years on average while taking over 90 morphine milligram equivalents daily. Dr. Padda explains opioid-induced hyperalgesia, where climbing doses make a person more sensitive to pain. Treating the pain source, he argues, changes the reason for the dose.
Read the full release on EIN Presswire
FDA Advisory Committee Convenes on Peptides: Understanding What Reclassification Means
EIN Presswire, July 20, 2026 · Patient education
Dr. Padda wrote this patient guide before an FDA advisory committee on compounding met in July to look at seven peptides. A lifted restriction, he explains, opened a review and is not a finding of safety. He names vials bought online as the main risk and says lab-guided prescribing under a physician’s oversight now matters more.
Read the full release on EIN Presswire
Patients Already on the Knee Replacement Waiting List Find Platelet-Rich Plasma Outperformed Cortisone and NSAIDs
EIN Presswire, July 19, 2026 · Research
Most injection studies leave out people whose knee arthritis is grade 3 or 4 and who are already on the surgical list, but this randomized trial enrolled only them. Across six months, two PRP injections outdid cortisone or an NSAID on pain, function and opioid use, and shifted blood markers of inflammation and of joint wear. Dr. Padda keeps his reading to what the trial measured.
Read the full release on EIN Presswire
Padda Institute Center for Interventional Pain Management Relocates to Expanded State-of-the-Art Facility
EIN Presswire, March 1, 2026 · Practice news
The practice’s larger outpatient facility on Woodson Road, a little under 18,000 square feet, puts interventional pain care beside metabolic medicine, concussion recovery and injury rehabilitation. Its team-based setup follows evidence that chronic pain and symptoms after an injury improve most when care is coordinated.
